Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT06223711
Title Durvalumab With Consolidative Radiochemotherapy and Ablative Stereotactic Radiotherapy in Oligometastatic ES-SCLC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Universitat des Saarlandes
Age Groups: senior | adult
Covered Countries DEU

No variant requirements are available.